This assay is intended for the in vitro quantitative measurement of hepatitis C virus（HCV）RNA in human plasma.This assay is suitable for patients who need to be diagnosed for HCV infection and for HCV undergoing antiviral treatment. The test results should not be used as the soleindicator for evaluating the patient's condition and must be combined with the patient'sclinical manifestations and other laboratory tests for a comprehensive analysis of thecondition. This assay is not intended for donor screening.

• High Accuracy 

Targets the highly conserved 5'UTR region to minimize false negatives caused by viral mutations.

• Broad Compatibility 

Robustly detects all major HCV genotypes (1-6) for global clinical applicability.

• Stable RNA Control 

Utilizes Armored RNA technology to prevent degradation and guarantee reliable quantification.

• Anti-Contamination 

Integrates a UNG enzyme system to prevent carryover contamination and ensure trustworthy results.